Changsong Qi

11PUBLICATIONS

43CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 23, 2026

Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.

|Mar 04, 2026

Allogeneic B7-H3-Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study.

Chang Liu, Jiarui Li, Dan Liu

|Nov 29, 2025

Impact of concomitant medications on efficacy of CLDN18.2-specific CAR-T cell therapy in advanced gastric cancer.

Jiarui Li, Lian Liu, Min Tao

|Oct 02, 2025

Optimizing CAR T cell therapy for solid tumours: a clinical perspective.

Jiarui Li, Chang Liu, Panpan Zhang

|Jul 10, 2025

A bispecific antibody-drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial.

Chang Liu, Dan Liu, Yinghua Ji

|Apr 17, 2025

Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancer.

Jiarui Li, Min Tao, Lian Liu

Pageof 2

Frequent Collaborators

Lin Shen

Chang Liu

Jian Li

Jiarui Li

Jifang Gong

Yanshuo Cao

Jiajia Yuan

Xiaotian Zhang

Licui Jiang

Huimin Meng

Frequent Collaborators

Lin Shen

Chang Liu

Jian Li

Jiarui Li